3651 Translation initiation factor eIF-2B delta subunit N-terminal helical domain
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Organic oxygen compounds | 4 | 1.0 | 4.08× | not tested | |
| Benzenoids | 1 | 0.4 | 2.77× | not tested | |
| Homogeneous non-metal compounds | 2 | 1.1 | 1.89× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
No DrugBank compounds are annotated on this group's domains.
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| RI2 | 1,5-di-O-phosphono-alpha-D-ribofuranose | 28 |
| RUB | RIBULOSE-1,5-DIPHOSPHATE | 12 |
| C7B | 2-(4-chloranylphenoxy)-~{N}-[4-[2-(4-chloranylphenoxy)ethanoylamino]cyclohexyl]ethanamide | 10 |
| MRU | 5-S-METHYL-1-O-PHOSPHONO-5-THIO-D-RIBULOSE | 4 |
| CL | CHLORIDE ION | 2 |